
Distinct Health shares surged 40% in HK grey market.

The offering has attracted a diverse group of cornerstone investors, including He Xiaopeng, Chairman and CEO of XPeng Motors (US$1 million), Mininglamp Technology (US$2 million), KingMed Diagnostics (US$3 million), and Health Vision, a consortium formed by Weimob, Kuro Games, and Shouhui Group, with a combined commitment of HKD 44 million (approx. $5.6 million USD).
Founded in 2012, Distinct Healthcare focuses on mid- to high-end integrated medical services. Frost & Sullivan data shows that, as of the end of 2024, the company ranked first among private mid- to high-end healthcare groups in China by number of cities covered, and second by patient visits.
The company operates a membership-based model, often compared to Costco, centered on family-oriented, multi-specialty care. In 2024, each customer averaged nearly four visits per year, while family members averaged over six visits annually, driving higher engagement and repeat consumption.
Revenue grew from RMB 473 million (approx. $65.7 million USD) in 2022 to RMB 959 million (approx. $133.2 million USD) in 2024, representing a 42.2% CAGR. The company turned profitable in 2024, and reported an adjusted net profit of approximately RMB 10.45 million (approx. $1.45 million USD) in the first eight months of 2025. Tencent is the largest institutional shareholder prior to the IPO, holding roughly 20% of the company.
Proceeds from the offering will primarily be used to deploy AI-driven healthcare technologies, upgrade existing facilities, and establish new medical centers.